Partnership expands doctor and patient access to advanced prognosis and coordinated care management of early-stage diabetic kidney disease
Company’s validated test available in the UK following implementation of UKHSA CTDA Regulations
PhRMA released a new report detailing the more than 260 medicines in development for 29 neurodegenerative diseases
Clene recently announced top-line data from RESCUE-ALS, a Phase 2 clinical trial evaluating CNM-Au8 as a disease modifying treatment for people with early amyotrophic lateral sclerosis (ALS).
Wilson Sonsini Goodrich & Rosati to open an office in Salt Lake City, becoming the latest major U.S. law firm to plant a flag in the tech-heavy region sometimes called “Silicon Slopes.”
Myriad Genetics announced financial results for its third quarter ended September 30, 2021 and provided an update on recent business performance and strategic transformation plans.
12 new hydrophilic-coated micro and support catheters cleared by FDA for broad use in the peripheral vasculature.
Utah has now become a VC darling with a maturing ecosystem complete with angels, seed-stage, growth stage, and private equity investors, says Brad Plothow, VP of strategy at St. George aerospace startup Intergalactic.
Fluidx Medical’s GPX Embolic Device Releases Initial Results for Oncology Drug Delivery
Home to the cutting-edge equipment and premier learning opportunities students need to meet workforce demand upon graduation, Dixie State University’s Science, Engineering & Technology Building was dedicated during a special Homecoming Week ceremony.
Udo announced the official launch of its new video-based healthcare collaboration app.
Bauer explains the two key factors he looks at when determining whether a medical device company is worth trying to turn around and more.